These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1978513)

  • 1. The role of iron in the basal ganglion.
    Youdim MB; Ben-Shachar D; Yehuda S; Riederer P
    Adv Neurol; 1990; 53():155-62. PubMed ID: 1978513
    [No Abstract]   [Full Text] [Related]  

  • 2. [The physiopathology of the basal ganglia and the etiopathogenesis of Parkinson's diseases].
    Stefanache F; Pendefunda L; Prodan R; Pendefunda G
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):145-54. PubMed ID: 2573122
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurotransmitters and their receptors in the basal ganglia.
    McGeer PL; McGeer EG
    Adv Neurol; 1993; 60():93-101. PubMed ID: 8093584
    [No Abstract]   [Full Text] [Related]  

  • 5. The possible role of iron in the etiopathology of Parkinson's disease.
    Youdim MB; Ben-Shachar D; Riederer P
    Mov Disord; 1993; 8(1):1-12. PubMed ID: 8419792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential nondopaminergic drugs for Parkinson's disease.
    Silverdale MA; Fox SH; Crossman AR; Brotchie JM
    Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
    [No Abstract]   [Full Text] [Related]  

  • 7. Basal ganglia pathophysiology in Parkinson's disease.
    Montgomery EB
    Ann Neurol; 2009 May; 65(5):618; author reply 618-9. PubMed ID: 19475660
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
    Dexter DT; Sian J; Jenner P; Marsden CD
    Adv Neurol; 1993; 60():273-81. PubMed ID: 8420143
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in functional interrelations of neuromediator systems during aging and the development of neuropsychological pathology of old age (review)].
    Burchinskiĭ SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1394-1400. PubMed ID: 2866651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of the basal ganglia in voluntary movement--a new concept].
    Kimura M
    No To Shinkei; 1993 Jul; 45(7):605-16. PubMed ID: 8104446
    [No Abstract]   [Full Text] [Related]  

  • 11. [Features of visual contrastometry in patients with basal ganglia dysfunction].
    Iakimovskiĭ AF; Shelepin IuE; Avtonomov VV
    Fiziol Cheloveka; 1993; 19(3):47-51. PubMed ID: 8354450
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
    Wichmann T; DeLong MR
    Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
    [No Abstract]   [Full Text] [Related]  

  • 13. The current model of basal ganglia organization under scrutiny.
    Parent A; Cicchetti F
    Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructural chemoanatomy of the basal ganglia: an overview.
    Pasik P; Pasik T; Holstein GR
    Adv Neurol; 1987; 45():59-66. PubMed ID: 2881451
    [No Abstract]   [Full Text] [Related]  

  • 15. T1-weighted hyperintensity in basal ganglia at brain magnetic resonance imaging: are different pathologies sharing a common mechanism?
    Herrero Hernandez E; Valentini MC; Discalzi G
    Neurotoxicology; 2002 Dec; 23(6):669-74. PubMed ID: 12520756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism associated with basal ganglia cryptococcal abscesses in an immunocompetent patient.
    Camargos ST; Teixeira AL; Cardoso F
    Mov Disord; 2006 May; 21(5):714-5. PubMed ID: 16437588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI assessment of basal ganglia iron deposition in Parkinson's disease.
    Wallis LI; Paley MN; Graham JM; Grünewald RA; Wignall EL; Joy HM; Griffiths PD
    J Magn Reson Imaging; 2008 Nov; 28(5):1061-7. PubMed ID: 18972346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Striato-cerebellar degeneration in a case of Parkinson's syndrome].
    Bignami A
    Acta Neurol (Napoli); 1967; 22(2):274-80. PubMed ID: 5606832
    [No Abstract]   [Full Text] [Related]  

  • 19. Contributions of neurochemistry to neurology and psychiatry. Introduction.
    Roberts E
    Fed Proc; 1973 Feb; 32(2):181-2. PubMed ID: 4143952
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new history of basal ganglia and physiopathology of Parkinson's disease].
    Reinoso Suárez F
    An R Acad Nac Med (Madr); 2001; 118(4):771-88; discussion 788-92. PubMed ID: 12056254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.